Nanobodies
Therapeutic Nanobodies and Intrabodies Rewriting the Rules of Target Engagement
David Alvaro, Ph.D.
Pharma's Almanac
PAO-05-25-NI-10May 27, 2025
Collaboration Agreement
BiondVax Signs Definitive Collaboration Agreement for the Development of a Pipeline of Innovative Nanosized Antibody (NanoAb) Therapies
BiondVax
PR-M03-22-11Mar 24, 2022
M&A
Aptar Acquires Nanopharm and Gateway Analytical, Broadening Pharma Services Platform to Accelerate Customer Drug Development
Aptar
PR-M06-19-NI-014Jun 13, 2019
Nanopharmaceuticals
Glycan-coated Gold Nanoparticles are Target of Nanofacturing Consortium
Nice Insight
PAO-M11-17-NI-041Nov 24, 2017